LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3148 | 3846 | 0.8192 | 0.7904 |
BT-20 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1097 | 2233 | 3846 | 0.5792 | 0.4746 |
BT-20 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1075 | 3673 | 0.2930 | -0.0116 |
BT-20 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 635 | 3673 | 0.1731 | -0.2694 |
BT-20 | Alvocidib | 10 | uM | LJP6 | 72 | hr | 1097 | 586 | 3673 | 0.1596 | -0.3025 |
BT-20 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2174 | 3673 | 0.5918 | 0.4792 |
BT-20 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1471 | 3673 | 0.4008 | 0.1835 |
BT-20 | GW843682X | 10 | uM | LJP6 | 72 | hr | 1097 | 1622 | 3673 | 0.4425 | 0.2500 |
BT-20 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3850 | 3846 | 1.0008 | 1.0003 |
BT-20 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3391 | 3846 | 0.8812 | 0.8641 |
BT-20 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2722 | 3846 | 0.7077 | 0.6515 |
BT-20 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3264 | 3673 | 0.8885 | 0.8687 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3320 | 3673 | 0.9036 | 0.8866 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3336 | 3673 | 0.9080 | 0.8919 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2796 | 3673 | 0.7610 | 0.7098 |
BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1560 | 3673 | 0.4252 | 0.2241 |
BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1097 | 627 | 3673 | 0.1708 | -0.2747 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 2626 | 3846 | 0.6824 | 0.6184 |
BT-20 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2260 | 3846 | 0.5873 | 0.4890 |
BT-20 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2963 | 3673 | 0.8073 | 0.7687 |
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3059 | 3673 | 0.8331 | 0.8010 |
BT-20 | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2370 | 3673 | 0.6458 | 0.5549 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1812 | 3673 | 0.4932 | 0.3327 |
BT-20 | PF562271 | 10 | uM | LJP6 | 72 | hr | 1097 | 700 | 3673 | 0.1909 | -0.2270 |
BT-20 | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1359 | 3673 | 0.3699 | 0.1300 |